Radiation-Induced Cognitive Decline: Challenges and Solutions.

Area of Science:

• Neuroscience
• Oncology
• Radiology

Background:

• Radiation therapy for central nervous system cancers can lead to radiation-induced cognitive decline (RICD).
• RICD involves impaired memory and attention, stemming from white matter damage, inflammation, and oxidative stress.
• The condition's complexity arises from diverse injury mechanisms and confounding factors like age and comorbidities.

Purpose of the Study:

• To explore the mechanisms and challenges of radiation-induced cognitive decline (RICD).
• To review current and emerging strategies for mitigating and managing RICD.
• To emphasize the importance of addressing cognitive function in cancer survivorship.

Main Methods:

• Literature review of mechanisms of RICD.
• Analysis of neuroprotective agents and cognitive rehabilitation techniques.
• Evaluation of advanced imaging (MRI) and therapeutic modalities (proton therapy).

Main Results:

• RICD is multifactorial, involving neurogenesis, oxidative stress, inflammation, and vascular effects.
• Neuroprotective agents, cognitive rehabilitation, advanced imaging, and proton therapy show promise.
• Personalized medicine and regenerative therapies offer future treatment avenues.

Conclusions:

• Managing RICD requires a multidisciplinary approach, integrating various therapeutic strategies.
• Personalized medicine and emerging therapies like stem cell treatments hold significant potential for RICD.
• Addressing cognitive decline is crucial for improving the quality of life for cancer survivors.